40
6
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1955L |
PKC β pseudosubstrate acetate
PKC β pseudosubstrate醋酸盐,Protein kinase C beta pseudosubstrate,PKC beta pseudosubstrate,PKC β pseudosubstrate acetate (172308-76-8 Free base) |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC β pseudosubstrate acetate (PKC β pseudosubstrate acetate (172308-76-8 Free base)) 是一种选择性的、细胞渗透的 PKC 抑制剂。 | |||
TP1956L |
PKC ζ pseudosubstrate acetate
PKC ζ pseudosubstrate acetate (799764-07-1 free base) |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC ζ pseudosubstrate acetate 是蛋白激酶 C (PKC) ζ 的抑制剂;附着于细胞通透性触角足结构域载体肽。由 PKC ζ 假底物结构域的氨基酸 113-129 组成,通过二硫键连接到触角足结构域载体肽。 Antennapedia 肽在 4 或 37°C 时被完整细胞积极吸收,确保快速有效地吸收抑制肽。一旦进入细胞,二硫键在细胞质中被还原,导致抑制肽的释放。通过 PKC ζ 非依赖性途径诱导肥大细胞脱粒。 | |||
T8376 |
PKCβ inhibitor 1
KUN79359 |
Apoptosis; PKC | Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCβ inhibitor 1 (KUN79359) 是一种 ATP 竞争性和选择性PKCβ抑制剂,对人 PKCβ1 和 PKCβ2 的IC50分别为 21 和 5 nM。 | |||
T35827L |
PKCε Inhibitor Peptide acetate
PKCε Inhibitor Peptide acetate(182683-50-7 Free base) |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCε Inhibitor Peptide acetate 是一种特异性 PKCε 抑制剂,含有其特定受体活化 C 激酶 (RACK) 的位点。 PKCε Inhibitor Peptide acetate 抑制 PKCε 的转运,但不抑制 αPKC,βPKC 和 δPKC 的转运。 | |||
T8764 |
PKC-iota inhibitor 1
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC-iota inhibitor 1 是一种蛋白激酶 C-iota(PKC-ι ℩)的抑制剂,IC50值为 0.34 μM。 | |||
T5817 |
PKC-theta inhibitor hcl
PKC-theta inhibitor |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC-theta inhibitor hcl 是一种选择性 PKC-θ 抑制剂 (IC50:12 nM)。 | |||
T35827 |
Epsilon-V1-2
PKCε Inhibitor Peptide,Protein Kinase Cɛ Inhibitor Peptide,ɛV1-2 |
||
Protein kinase C (PKC ) is a calcium-independent, phospholipid- and diacylglycerol-dependent serine/threonine kinase involved in diverse signaling pathways, including those involved in neuronal signaling, cytoskeletal function, and inflammation.[1] PKC inhibitor peptide is a synthetic peptide corresponding to an amino acid sequence found in the amino terminal C2 domain of most mammalian forms of PKC .[2] It selectively and reversibly inhibits the translocation of PKC to intracellular membrane... | |||
T40101 |
(±)-1,2-Diolein
1,2-Dioleoyl-rac-glycerol,甘油1,2-二油酸酯 |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
(±)-1,2-Diolein (1,2-Dioleoyl-rac-glycerol) 是一种PKC 激活剂,可以增加肌小管 Ca2+内流。 | |||
T35826 |
PKC fragment (530-558)
|
||
PKC fragment (530-558) 是蛋白激酶C (PKC) 的肽片段,是一种有效的 PKC 激活剂。Protein Kinase C (530-558) 可显著抑制破骨细胞骨吸收。 | |||
T75885 |
PKC β pseudosubstrate TFA
|
||
PKCβ pseudosubstrate TFA 是一种选择性的、细胞渗透的 PKC 抑制剂。 | |||
T76412 |
PKCδ Peptide Substrate
|
||
PKCδPeptide Substrate 是一种δ-typePKC 的特异性底物,其序列与含有 Thr-431 的小鼠 eEF-1α 序列 422-443 相对应。 | |||
T80071 |
PKCζ/ι pseudosubstrate inhibitor
|
||
PKCζ/ι偽基質抑制劑對PKC酶家族表現廣譜抑制作用,並可能促成記憶功能障礙。 | |||
T61604 |
PKC-IN-4
|
||
PKC-IN-4 (compound 7l) is a highly potent and orally active inhibitor of atypical protein kinase C (aPKC), exhibiting an IC 50 value of 0.52 μM. In vitro studies have demonstrated that PKC-IN-4 effectively suppresses NF-κB activity induced by TNF-α. Moreover, this compound effectively impedes the permeability of the retinal vasculature, induced by both VEGF and TNFα. [1] | |||
T83754 |
PKCδ Substrate TFA
Protein Kinase Cδ Substrate |
||
PKCδ substrate是一种用于PKCδ的肽基底,常用于无细胞及细胞内测定中监测PKCδ活性。 | |||
T12494 |
PKC-IN-1
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC-IN-1 是 ATP-竞争性可逆 PKC 抑制剂,对人 PKCβ 和 PKCα 的 Ki 值分别为 5.3 和 10.4 nM,对人 PKCα、PKCβI、PKCβII、PKCθ、PKCγ、PKC mu 和 PKCε 的IC50值分别为 2.3、8.1、7.6、25.6、57.5、314 和 808 nM。 | |||
T71993 |
PKC-9
|
||
PKC-9 is a PKC-zeta inhibitor 9. | |||
T80248 |
PKCε (85-92)
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCε(85-92) 是一种具有生物活性的肽,其作为 e-PKC 特异性激活剂,能够促进野生型细胞中的 MARCKS 磷酸化作用,对基因敲除小鼠来源的细胞中的 MARCKS 磷酸化则无影响。 | |||
T62945 |
Aurora A/PKC-IN-1
|
||
Aurora A/PKC-IN-1 (Compound 2e) 是一种有效的 Aurora A (AurA) 和 PKC (α, β1, β2, θ) 双重抑制剂,作用于 AurA (IC50: 6.9 nM) 和 PKCα (IC50: 16.9 nM)。Aurora A/PKC-IN-1 对乳腺癌细胞表现出抗增殖和抗转移作用。 | |||
T81450 |
PKCε Inhibitor Scramble Peptide
|
||
PKCε Inhibitor Scramble Peptide为一Scramble肽,其氨基酸序列与PKCε抑制肽相同。 | |||
T80504 |
ɛPKC(85–92),Myristoylated
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC(85-92),Myristoylated 是一种结合肉豆蔻酸的细胞渗透性肽,作为 PKC 激活剂,可以增强HUVECs的NO释放。 | |||
T5423 |
PKC-theta inhibitor
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC-theta inhibitor 是一种PKC-θ抑制剂,IC50值为 12 nM。 | |||
T80511 |
PKCε inhibitor peptide,myristoylated
Myr‐PKCɛ- |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Myristoylated PKCε inhibitor peptide(Myr-PKCε-)是一种与肉豆蔻酸偶联、具有细胞渗透性的PKCε蛋白激酶Cε亚型特异性肽抑制剂,它能够降低人脐静脉内皮细胞(HUVECs)的一氧化氮(NO)释放。 | |||
T80508 |
PKCη pseudosubstrate inhibitor,myristoylated
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Myristoylated PKCη pseudosubstrate inhibitor 是一种具有细胞渗透性的化合物,它主要应用于研究PKCη的作用机制。 | |||
T80509 |
PKC 20-28,myristoylated
Myristoylated protein kinase C inhibitor 20-28 |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC20-28,myristoylated(Myristoylated protein kinase C inhibitor 20-28)为具细胞渗透性之PKC抑制剂,可抑制AngII所诱导之IKca电流激活,用途涵盖癌症与心血管疾病研究。 | |||
T80507 |
PKCθ pseudosubstrate peptide inhibitor,myristoylated
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Myristoylated PKCθ pseudosubstrate peptide inhibitor 是一款合成肽,专门用于研究 PKCθ 的机制。 | |||
T80070 |
PKCβII Peptide Inhibitor I
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCβII Peptide Inhibitor I 为一种特定的PKCβII抑制剂。在大鼠心脏缺血/再灌注损伤模型中,该化合物显著表现出心脏保护效应,并能有效预防血管内皮功能障碍。 | |||
T81449 |
PKC-ε translocation inhibitor peptide
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKC-ε translocation inhibitor peptide,作为一种特定的PKC-ε易位抑制剂,能够特异性地调控FcγR介导的调理珠内化速率,而对FcαR运输不产生影响。 | |||
T80505 |
PKCα (C2-4) inhibitor peptide
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCα(C2-4) inhibitor peptide为专一性PKCα抑制剂,能够抑制α1A‐肾上腺素受体激动剂A-61603对IKr通道的影响。 | |||
T9863 |
PKCiota-IN-2
PKCiota-IN-49 |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCiota-IN-2 (PKCiota-IN-49) 是一种有效的 PKCiota (PKC-ι) 抑制剂,IC50 为 2.8 nM。PKCiota-IN-2 还抑制 PKC-α 和 PKC-ε,IC50 分别为 71 nM 和 350 nM。 | |||
T10549 |
Bisindolylmaleimide VIII acetate
Ro 31-7549 acetate,Bis VIII acetate |
Apoptosis; PKC | Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling |
Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate) 是一种选择性蛋白激酶 C 抑制剂。它促进 Fas 介导的细胞凋亡,并抑制 T 细胞介导的自身免疫性疾病。 | |||
T6643 |
Ro 31-8220 Mesylate
Ro 31-8220 methanesulfonate,Bisindolylmaleimide IX,Bisindolylmaleimide IX mesylate |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Ro 31-8220 Mesylate (Bisindolylmaleimide IX mesylate) 是PKC 抑制剂,对 PKCα、PKCβI、PKCβII、PKCγ、PKCε 和大鼠大脑 PKC 的IC50值为 5、24、14、27、24 和 23 nM。它还抑制 MAPKAP-K1b、MSK1、S6K1 和 GSK3β,IC50为3、8、15 和 38 nM。 | |||
T3689 |
Ruboxistaurin hydrochloride
Ruboxistaurin,LY333531 HCl,LY 333531 hydrochloride,芦布妥林 |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Ruboxistaurin hydrochloride (LY 333531 hydrochloride) 是蛋白激酶 C(PKC) 的同工酶选择性抑制剂,竞争性且可逆地抑制 PKCβI 和 PKCβII,IC50 值分别为 4.7 和 5.9 nM。 | |||
T72919 | PKCiota-IN-1 | ||
PKCiota-IN-1 是一种有效的 PKCiota (PKC-ι)抑制剂,IC50为 2.7 nM。PKCiota-IN-1 还抑制PKC-α和PKC-ε,IC50分别为 45 nM 和 450 nM。 | |||
T76388 |
Protein kinase C α peptide TFA
|
||
Protein kinase C α peptide (TFA) 为PKC-α的脂质依赖性丝氨酸/苏氨酸蛋白激酶多肽片段,关键调节细胞生存、增殖、分化、迁移及粘附等过程。 | |||
T69914 |
Variegatic acid
|
||
Variegatic acid is a natural inhibitor of β-hexosaminidase release and tumor necrosis factor (TNF)-α secretion from rat basophilic leukemia (RBL 2H3) cells, with IC50 values of 10.4 μM and 16.8 μM, respectively, also inhibiting PKC β1 activity with an IC50 value of 36.2 μM. | |||
T69438 |
MT477
|
||
MT477 is PKC-α inhibitor. MT477 interfered with PKC activity as well as phosphorylation of Ras and ERK1/2 in H226 human lung carcinoma cells. It also induced poly-caspase-dependent apoptosis. MT477 had a dose-dependent (0.006 to 0.2 mM) inhibitory effect on cellular proliferation of H226, MCF-7, U87, LNCaP, A431 and A549 cancer cell lines as determined by in vitro proliferation assays. | |||
T74691 |
Aprinocarsen sodium
|
||
Aprinocarsen (ISIS 3521) sodium,是针对蛋白激酶C-α(PKC-α)的特异性反义寡核苷酸抑制剂,为一种20-mer寡核苷酸,通过调节细胞分化和增殖来发挥作用。其能有效抑制人类肿瘤细胞系在裸鼠体内的生长,展示了作为人类癌症化疗化合物的潜力。 | |||
T78833 | AJH-836 | PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
AJH-836为Munc13-1及PKCε/α激活剂(Kd:4.5 nM PKCα),促进Munc13-1由细胞质转位至质膜,并可应用于神经退行性疾病研究。 | |||
T17299 |
(-)-Indolactam V
Indolactam V |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
(-)-Indolactam V is a PKC activator (Kis: 3.36 nM, 1.03 μM for η-CRD2 , γ-CRD2). (-)-Indolactam V also has the Kds are 5.5 nM (η-C1B), 7.7 nM (ε-C1B), 8.3 nM (δ-C1B), 18.9 nM (β-C1A-long), 20.8 nM (α-C1A-long), 137 nM (β-C1B), 138 nM (γ-C1A), 213 nM (γ-C1 | |||
T35536 |
Tpl2 Kinase Inhibitor (hydrochloride)
|
||
Tpl2 kinase inhibitor is an inhibitor of tumor progression locus 2 (Tpl2; IC50= 0.05 μM).1It is selective for Tpl2 over MEK, p38 MAPK, Src, MK2, and PKC (IC50s = >40, 180, >400, 110, and >400 μM, respectively). Tpl2 kinase inhibitor inhibits LPS-induced TNF-α production in isolated human monocytes and whole blood (IC50s = 0.7 and 8.5 μM, respectively). It enhances differentiation induced by calcitriol in HL-60 and U937 leukemia cells when used at a concentration of 5 μM.2Tpl2 kinase inhibitor (5... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2A2481 |
Taurochenodeoxycholic Acid
Chenodeoxycholyltaurine,TCDCA,Chenyltaurine,Taurochenodeoxycholate,12-Deoxycholyltaurine,牛磺鹅去氧胆酸 |
Apoptosis; TNF; Caspase; Endogenous Metabolite | Apoptosis; Metabolism; Proteases/Proteasome |
Taurochenodeoxycholic Acid (12-Deoxycholyltaurine) 是动物胆汁酸的主要生物活性物质之一,可诱导细胞凋亡,具有明显的抗炎和免疫调节作用。 | |||
TN2215 |
Taurochenodeoxycholic acid sodium
牛磺鹅去氧胆酸钠盐,Sodium taurochenodeoxycholate,牛磺鹅去氧胆酸钠 |
Apoptosis; Endogenous Metabolite | Apoptosis; Metabolism |
Taurochenodeoxycholic acid sodium (Sodium taurochenodeoxycholate) 是动物胆汁酸的主要生物活性物质之一。它可诱导细胞凋亡,具有抗炎和免疫调节作用。 | |||
TN1047 |
Ingenol mebutate
Ingenol 3-Angelate,巨大戟醇甲基丁烯酸酯,PEP005 |
gp120/CD4; HIV Protease; PKC | Chromatin/Epigenetic; Cytoskeletal Signaling; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Ingenol mebutate (Ingenol 3-Angelate) 是 PKC 的有效激动剂,包括 PKC-α、PKC-β、PKC-γ、PKC-δ 和 PKC-ε,Kis 为 0.3、0.105、0.162、0.376 和 0.171 nM。 Ingenol mebutate 具有抗炎和抗肿瘤活性。 | |||
TN1299 |
Desmethylglycitein
4',6,7-三羟基异黄酮,4',6,7-三羟异黄酮,6-羟基大豆苷元,6,7,4'-Trihydroxyisoflavone |
PI3K; CDK; PKC | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
Desmethylglycitein (6,7,4'-Trihydroxyisoflavone) 是大豆中苷元的代谢产物,具有抗氧化性和抗癌活性。它是蛋白激酶 C(PKC)α 的直接抑制剂,抑制正常人皮肤成纤维细胞中的太阳紫外线诱导的基质金属蛋白酶1。它在体内直接结合CDK1和CDK2,抑制 CDK1 和 CDK2 活性。 | |||
TN3655 |
Cimiside E
|
ERK; TNF; ROS; Akt; PI3K; PKC; PPAR | Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; Immunology/Inflammation; MAPK; Metabolism; PI3K/Akt/mTOR signaling |
Cimiside E has anti-inflammatory activity, it selectively inhibits TNF-α-induced expression of VCAM-1 at least by upregulation of PPAR-γ, and signals for ERK1/2, PI3K, and PKC are involved in this effect.Cimiside E may be an effective chemopreventive agen | |||
TN5593 | Euphohelioscopin A | ||
Euphohelioscopin A, an activator of protein kinase C (PKC), it inhibits proliferation and induces differentiation of the myeloid leukemia cell lines THP-1 and HL-60. Euphohelioscopin A has anti-inflammary activity, it exhibits moderate inhibitory activity |